LIFECORE BIOMEDICAL, INC. \DE\
For the period ended Feb 23, 2025. Filed Apr 3, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Feb 23, 2025 · Filed Apr 3, 2025
LFCR$6.36-0.6%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| LIFECORE BIOMEDICAL, INC. | |
|---|---|
| By: | /s/ Paul Josephs |
| Paul Josephs | |
| President and Chief Executive Officer | |
| (Principal Executive Officer) | |
| By: | /s/ Ryan D. Lake |
| Ryan D. Lake | |
| Chief Financial Officer and Secretary | |
| (Principal Financial and Accounting Officer) | |
Date: April 3, 2025
-43-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.